Results 231 to 240 of about 54,594 (319)

Engineering Bispecific Peptides for Precision Immunotherapy and Beyond. [PDF]

Int J Mol Sci
Ding X, Li Y.
europepmc   +1 more source

A review of targeted drug delivery with antibody-drug complexes. [PDF]

J Pharmacol Exp Ther
Sanjanwala D, Meng Y, Guo Z, Bordeau B.
europepmc   +1 more source

Integrated Imaging Probe and Bispecific Antibody Development Enables In Vivo Targeting of Glypican-3–Expressing Hepatocellular Carcinoma [PDF]

Peiman Habibollahi, Alexey Gurevich, James Z. Hui, Kelley Weinfurtner, George McClung, J Adler, Michael C. Soulen, David E. Kaplan, G. Nadolski, Stephen J. Hunt, Andrew Tsourkas, T. Gade   +11 more
openalex   +1 more source

MMP-cleavable linker platform for tumour-responsive homo- and heterobivalent antibody-drug conjugates. [PDF]

Chem Sci
Counsell AJ, Walsh SJ, Ashman N, Park M, Dannheim FM, King TA, Wharton T, Carroll JS, Spring DR.   +8 more
europepmc   +1 more source

1323 A novel bispecific antibody targeting CD137 and CLDN4 for treating patients with solid tumors [PDF]

Masahito Sato, Aya Kikuchi, Keita Nagaoka, Sumito Yoshida, Nicholas Souders, Masayasu Yoshino, Masayo Oishi, Hiroyuki Sayama, Takeshi Saito, Masashi Shimazaki, Kenna Shirasuna   +10 more
openalex   +1 more source

Mechanistic Insights and Advances of Bispecific T Cell Engaging Antibodies Therapy in Multiple Myeloma. [PDF]

Medicina (Kaunas)
Tang TF, Cheong CS, Looi CY, Wong WF, Gan GG.   +4 more
europepmc   +1 more source

1208 Comparison of receptor occupancy and optimal doses of PD1xCD40 and PDL1xCD40 bispecific antibodies using physiologically based pharmacokinetic modeling [PDF]

Alexandra Diakonova, Dmitry Shchelokov, Oleg Demin, Oleg Demin   +3 more
openalex   +1 more source

Engineering bispecific HER2xVEGF designed ankyrin repeat proteins for targeted nanobiotechnology applications. [PDF]

J Nanobiotechnology
Chen F, Bradbury MS.
europepmc   +1 more source

385 A bispecific engager-secreting TIL therapy designed to penetrate stromal barriers and boost tumor killing in solid tumors [PDF]

Jingwei Sun, Yiyang Tan, Jiahui Jin, Jingman Wang, Fengbiao Guo, Xu Zhao, Pin Wang, Yarong Liu   +7 more
openalex   +1 more source

Donor-Derived T-Cell Redirection With Epcoritamab Achieving Complete Response After Early Post-Allo-HSCT Relapse of DLBCL. [PDF]

EJHaem
Ikoma Y, Kaneda Y, Shimazu R, Okamoto D, Matsumoto T, Nakamura N, Nakamura H, Kanemura N, Goto H, Katsumura N, Shimizu M.   +10 more
europepmc   +1 more source